DMKC Advisory Services LLC Acquires New Position in The Clorox Company $CLX

Key Points

• DMKC Advisory Services LLC has acquired a new position in The Clorox Company, purchasing 4,126 shares valued at approximately $533,000.
• Clorox's recent earnings report showed a higher-than-expected EPS of $2.87, exceeding analyst predictions and reflecting a 4.5% year-over-year revenue growth.
• Analysts have recently lowered their price targets on Clorox, with a consensus rating of "Reduce" and a price target of $134.08.

DMKC Advisory Services LLC bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,126 shares of the company's stock, valued at approximately $533,000.

A number of other large investors have also recently modified their holdings of CLX. Wellington Management Group LLP grew its stake in shares of Clorox by 18.8% during the fourth quarter. Wellington Management Group LLP now owns 4,074 shares of the company's stock worth $662,000 after buying an additional 646 shares during the last quarter. Fifth Third Wealth Advisors LLC lifted its holdings in Clorox by 36.4% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 1,712 shares of the company's stock worth $252,000 after buying an additional 457 shares during the period. Rhumbline Advisers boosted its holdings in Clorox by 5.7% in the first quarter. Rhumbline Advisers now owns 273,462 shares of the company's stock valued at $40,267,000 after acquiring an additional 14,647 shares during the last quarter. Czech National Bank increased its position in Clorox by 5.4% during the 1st quarter. Czech National Bank now owns 28,294 shares of the company's stock valued at $4,166,000 after purchasing an additional 1,455 shares during the period. Finally, NBC Securities Inc. raised its holdings in Clorox by 123,850.0% during the 1st quarter. NBC Securities Inc. now owns 2,479 shares of the company's stock worth $365,000 after purchasing an additional 2,477 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Ratings Changes

Several research firms have recently weighed in on CLX. Wells Fargo & Company decreased their price objective on shares of Clorox from $130.00 to $125.00 and set an "equal weight" rating for the company in a research report on Thursday, September 25th. Barclays cut their price target on shares of Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a research report on Tuesday. TD Cowen lowered their price objective on Clorox from $120.00 to $117.00 and set a "hold" rating for the company in a research report on Wednesday. Zacks Research raised Clorox from a "strong sell" rating to a "hold" rating in a research note on Monday. Finally, The Goldman Sachs Group decreased their target price on Clorox from $115.00 to $110.00 and set a "sell" rating for the company in a research note on Wednesday. One investment analyst has rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat, Clorox has a consensus rating of "Reduce" and a consensus price target of $134.08.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.57% of the company's stock.

Clorox Stock Performance

Shares of CLX opened at $122.64 on Thursday. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a market cap of $15.00 billion, a PE ratio of 18.81, a P/E/G ratio of 0.99 and a beta of 0.52. The stock has a 50-day moving average of $123.15 and a 200-day moving average of $129.96. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the prior year, the business earned $1.82 EPS. The firm's revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox's dividend payout ratio (DPR) is presently 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.